NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	13/03/2020
Target sample size	750
Countries of recruitment	Japan,North America,Europe
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 333 Anticoagulants Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : Apixaban Therapeutic category code : 333 Anticoagulants Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	safety
Secondary Outcome	safety

Key inclusion & exclusion criteria

Age minimum	>= 45age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria